Overview

• Titan Medical's proposed merger with Conavi Medical will be voted on by shareholders at the annual meeting on September 30, 2024.
• Independent advisory firm ISS recommends shareholders vote in favor of the merger, highlighting its potential to enhance shareholder value.
• The merger is expected to improve Titan's balance sheet and benefit from reduced listing requirements on the TSXV.
• Conavi Medical will present an overview of its patented Novasight Hybrid™ System at a Titan Q&A session on September 19, 2024.
• Titan and Conavi's management teams will address shareholder questions during the Q&A session, providing further details on the merger.